Shanghai Junshi Biosciences Co., Ltd. (SHJBF)
USD 1.24
(0.0%)
USD 1.24
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.45 Billion CNY | -505.27% |
| 2022 | -409.07 Million CNY | -289.84% |
| 2021 | -104.93 Million CNY | 57.3% |
| 2020 | -245.73 Million CNY | -109.56% |
| 2019 | -117.25 Million CNY | -12.04% |
| 2018 | -104.66 Million CNY | -135.51% |
| 2017 | -44.44 Million CNY | -81.14% |
| 2016 | -24.53 Million CNY | 69.75% |
| 2015 | -81.09 Million CNY | -91.77% |
| 2014 | -42.28 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -322.38 Million CNY | -1.81% |
| 2024 Q1 | -43.79 Million USD | 65.7% |
| 2024 Q3 | -46.92 Million USD | -2.03% |
| 2023 Q2 | -71.91 Million USD | 27.28% |
| 2023 Q4 | -130.31 Million USD | -135.26% |
| 2023 Q3 | -55.39 Million CNY | 22.98% |
| 2023 FY | -2.47 Billion CNY | -505.27% |
| 2023 Q1 | -98.89 Million USD | 25.9% |
| 2022 Q2 | -97.94 Million USD | -59.2% |
| 2022 Q4 | -133.46 Million CNY | -19.8% |
| 2022 FY | -409.07 Million CNY | -289.84% |
| 2022 Q3 | -111.4 Million CNY | -13.75% |
| 2022 Q1 | -61.51 Million USD | -53.47% |
| 2021 Q1 | 68.77 Million USD | 0.0% |
| 2021 FY | -104.93 Million CNY | 57.3% |
| 2021 Q4 | -40.08 Million USD | 36.29% |
| 2021 Q3 | -62.92 Million USD | 13.13% |
| 2021 Q2 | -72.43 Million USD | -205.32% |
| 2020 FY | -245.73 Million CNY | -109.56% |
| 2019 FY | -117.25 Million CNY | -12.04% |
| 2018 FY | -104.66 Million CNY | -135.51% |
| 2017 FY | -44.44 Million CNY | -81.14% |
| 2016 FY | -24.53 Million CNY | 69.75% |
| 2015 FY | -81.09 Million CNY | -91.77% |
| 2014 FY | -42.28 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -3323.289% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 50100.75% |
| SQZ Biotechnologies Company | -75.82 Million USD | -3140.939% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -13669.498% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 3102.303% |
| Mesoblast Limited | -84.14 Million USD | -2820.416% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -159884.633% |
| Genus plc | 6.4 Million USD | 38497.537% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 25324.046% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -263749.594% |
| Marizyme, Inc. | -34.08 Million USD | -7109.427% |
| ContraFect Corporation | -56.88 Million USD | -4219.714% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -29330.447% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -53853.681% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -175182.32% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -86110.711% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -89234.285% |
| MultiCell Technologies, Inc. | -722.81 USD | -339984453.755% |
| Accustem Sciences Inc. | -3.74 Million USD | -65494.434% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -4065.863% |
| EV Biologics, Inc. | -483.06 Thousand USD | -508621.935% |
| Q BioMed Inc. | -3.44 Million USD | -71220.842% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 69519.276% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -630708.931% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -93426.994% |
| Biomind Labs Inc. | -1 Million USD | -243306.8% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -50262.131% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -36865.054% |
| Skye Bioscience, Inc. | -13.67 Million USD | -17874.534% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -123608.449% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -8204501.873% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -48615.445% |
| IMV Inc. | -38.67 Million USD | -6254.658% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -15385.086% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -127056.661% |
| GB Sciences, Inc. | -1.42 Million USD | -172897.31% |
| Alpha Cognition Inc. | -9.7 Million USD | -25219.837% |
| HST Global, Inc. | -140.9 Thousand USD | -1743917.226% |
| CSL Limited | 3.7 Billion USD | 166.381% |
| Halberd Corporation | -75.05 Thousand USD | -3274306.866% |
| Enzolytics Inc. | -2.14 Million USD | -114263.475% |
| Resverlogix Corp. | -12.74 Million USD | -19175.569% |
| Affymax, Inc. | -15.04 Million USD | -16232.862% |
| SYBLEU INC | -149.18 Thousand USD | -1647200.143% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -77464.073% |
| argenx SE | -425.04 Million USD | -478.155% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -4327.186% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -235287.199% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -155497.846% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -72072.027% |
| AVAX Technologies, Inc. | 6.69 Million USD | 36817.263% |
| Zenith Capital Corp. | -8.94 Million USD | -27378.948% |
| Genscript Biotech Corporation | -415.79 Million USD | -491.028% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -14106107.181% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -99986.561% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -1432731.289% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -4370.324% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -84602.882% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -249626.626% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -131710.872% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -195556.238% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -122480.56% |
| BioStem Technologies, Inc. | -7.77 Million USD | -31490.849% |
| ONE Bio Corp. | 13.68 Million USD | 18061.726% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -1353974.636% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -183918.669% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -218357.574% |
| Agentix Corp. | -1.37 Million USD | -179045.734% |
| LadRx Corporation | -3.82 Million USD | -64169.946% |
| Cell Source, Inc. | -4.32 Million USD | -56714.931% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -591372.097% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -357632.346% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -357632.346% |
| NovAccess Global Inc. | -2.46 Million USD | -99522.272% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -84075.013% |
| Itoco Inc. | -919.14 Thousand USD | -267263.226% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -57880.234% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -219510.577% |
| Kadimastem Ltd | -3.04 Million USD | -80730.272% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -938837.038% |
| CytoDyn Inc. | -18.05 Million USD | -13508.608% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -9763278.439% |
| Mobile Lads Corp. | -554.55 Thousand USD | -443041.71% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -1116523.358% |
| Qrons Inc. | -643.67 Thousand USD | -381681.911% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -435058.893% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -110105.188% |
| Rebus Holdings, Inc. | -664 Thousand USD | -369996.74% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -135197.874% |
| International Stem Cell Corporation | -663 Thousand USD | -370554.955% |
| Bioxytran, Inc. | -3.82 Million USD | -64228.476% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -4668293.528% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -12081720.811% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -6676.16% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -151781.48% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -333866.494% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -78892.04% |
| Neutra Corp. | -229.48 Thousand USD | -1070746.306% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -13911.303% |
| PureTech Health plc | -146.19 Million USD | -1580.889% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -11334.687% |
| IXICO plc | -1.43 Million USD | -170911.994% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -25792.344% |
| Gelesis Holdings, Inc. | -121.8 Million USD | -1917.505% |
| CSL Limited | 3.81 Billion USD | 164.466% |
| Cellectis S.A. | -108.85 Million USD | -2157.489% |